Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial-Reference-Cited by-同舟云学术

Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial

Published:1999-05 Issue:9166 Volume:353 Page:1735-1742
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sandström Eric,Wahren Britta

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Reduction of HIV concentration during acute infection: independence from a specific immune response;Philllips;Science,1996

2. Role of cellular immunity in protection against HIV infection;Rowland-Jones;Adv Immunol,1997

3. Heeney JL, Beverly P, McMichael A, et al. Understanding the immune correlates of protection from HIV infection and disease progression to AIDS: more answers but yet more questions. Immunol Today (in press).

4. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia;Rosenberg;Science,1997

5. Coreceptor useage of primary immunodeficiency virus type 1 isolates varies according to biological phenotype;Björndal;J Virol,1997

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The doctor's dilemma and vaccine therapy for HIV;The Lancet HIV;2016-10

2. Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission;The Lancet Infectious Diseases;2015-09

3. Immunotherapy with an HIV-DNA Vaccine in Children and Adults;Vaccines;2014-07-17

4. Immune Intervention in AIDS;Immunology of Infectious Diseases;2014-04-09

5. Shot in the HAART: vaccine therapy for HIV;The Lancet Infectious Diseases;2014-04